W WearScoredoes this wearable serve the patient?
← All devices Bardy CAM Patch
Clinical / medical-grade · Patch / sensor · by Baxter

Bardy CAM Patch

A P-wave-centric 14-day ECG patch (Zio rival) — cardiologist-grade, but clinician-mediated with no patient data access.
Cardiovascular
2019Bardy CAM (14-day; now Baxter)
Late in cycle6 yr 9 mo old
API access: No Raw data access: No Open source: No public repo
Clinical value
88/100
P-wave-centric 14-day ECG patch
Empowerment
24/100
Clinician-only; no patient access
Everyday value
42/100
Single-use chest patch
A prescription 14-day ambulatory ECG patch (now part of Baxter) placed over the sternum to optimize P-wave capture — clinically excellent, with studies showing more arrhythmias detected than the Zio XT, but, like the Zio, clinician-mediated with no patient-facing data.
What it measures
Single-lead, P-wave-centric continuous ECG over up to 14 days for arrhythmia detection, worn over the sternum.
Regulatory status
FDA 510(k)-cleared; prescription/physician-ordered. P-wave-centric design for clearer atrial-signal capture.
Validation & accuracy
Company studies report 40% more arrhythmias detected than the Zio XT and 2.8× more patients with arrhythmias than Holter; published P-wave-clarity research.
Data control & export
Raw data: no — the patch is returned/uploaded and a report goes to the ordering clinician via the BDxCONNECT portal; the patient gets no app or raw data. API: none for patients.
Wearability & battery
A lightweight single-use sternal patch worn continuously up to 14 days (showers, sleep, exercise), then returned.
Cost & access
Prescription/physician-ordered; billed through insurance like other ambulatory monitors.
Who it serves
Highest clinical integration; the patient is the monitored subject, not the data owner.
Who is left out or burdened
Prescription gatekeeping; no patient data access, app, or export.
✓ Strengths
  • P-wave-centric design for clearer arrhythmia diagnosis
  • Detected more arrhythmias than Zio XT in company studies
  • Comfortable single sternal patch; 96% patient preference vs Holter
  • Option for clinics to analyze with their own technicians
✕ Weaknesses
  • Patient gets no raw data, app, or export
  • Prescription / physician-ordered only
  • Single-use device
  • Depends entirely on the clinician to relay results
88
Why this clinical score. A cleared, P-wave-optimized 14-day monitor with strong comparative data — near the top of the clinical axis alongside the Zio.
24
Why this empowerment score. Like the Zio, the patient never receives raw data, has no app, and needs a prescription — among the lowest empowerment scores here.
42
Why this everyday score. Comfortable to wear and forget for two weeks, but single-use, single-purpose, and prescription-bound.
Reviews & coverage

Reviewers and cardiologists note the Bardy CAM patch's P-wave-centric placement for clearer arrhythmia capture. As a prescription, clinic-managed monitor, it's evaluated on diagnostic yield rather than consumer features.

Summary is a draft synthesis of public coverage, not an endorsement. Links open a search of each outlet.
Reddit communities
Independent user communities where this device (or its category) is discussed.
Draft profile · public-source review, June 2026 · scores describe direction and degree, not buying advice. News, links, and prices change — verify with the manufacturer. Image is representative.